佳达修疫苗(Gardasil)是一种四价人乳头瘤病毒疫苗,可以预防人乳头瘤病毒主要致癌亚型(HPV 6、11、16和18型)的感染。它通过激活人体的免疫系统来产生抗体,从而预防HPV感染和相关疾病的发生,特别是宫颈癌和生殖器疣。 2. 预防宫颈癌的效果 佳达修疫苗可以在HPV感染前或感染早期以及相关疾病发展之前提供保护。它被广泛...
人乳头瘤病毒(Human Papillomavirus,HPV)是一种常见的性传播病原体,感染不同型别的HPV与宫颈癌的发生密切相关。为了预防宫颈癌,疫苗推出了多种类型,其中四价人乳头瘤病毒疫苗佳达修(Gardasil)是其中一种。就像其他疫苗和药物一样,佳达修也有可能出现耐药问题,同时还存在与其他药物的相互作用。本文将探讨佳达修的耐药性...
对于超过26岁或已有性生活者,虽然感染HPV的机率增加,但一个女性同时感染多种HPV亚型的机率不大,所以这部分人群接种HPV疫苗也可能获得一定程度的保护作用。 HPV预防性疫苗的有效性 研究发现,4价疫苗(Gardasil)估计可预防70%以上由HPV16和18型宫颈癌以及约90%...
HPV4 Gardasil Exceeds All other Vaccine-Induced Abortion/Stillbirth Eventsdoi:http://holyhormones.com/womens-health/menstrual-cycle/hpv-4-gardMedAlerts Blog entry for November 2010 By Steven Rubin It has been suggested that the H1N1 Flu vaccine causes miscarriages (see, for exampl...
HPV预防性疫苗的有效性 研究发现,4价疫苗(Gardasil)估计可预防70%以上由HPV16和18型宫颈癌以及约90%肛门癌, 另外还能预防HPV6和11型引起的尖锐湿疣。此外,Meta分析显示,4价疫苗有效降低了CIN 2-3/AIS的发病率,保护效果可达97%,对降低VIN 2-3/VaIN 2-3发病率的作用也可达95%。
I thought an ounce of prevention was worth a pound of cure. Little did I realize how my simple decision to add Gardasil to my cancer prevention strategy would result in so many new health conditions. Sometimes, I wish it were possible to get unvaccinated. ...
On October 16, 2009, the Food and Drug Administration licensed quadrivalent human papillomavirus vaccine (HPV4; Gardasil, Merck & Co. Inc.) for use in male... Centers for Disease Control and Prevention (CDC) - 《Mmwr Morb Mortal Wkly Rep》 被引量: 359发表: 2010年 FDA Licensure of Quadri...
Vaccines Many women may not associate vaccines with their OB/GYN, but there are a number that you can get during your appointment with us, including Gardasil, the HPV vaccine. These vaccines are very important to your health, even, and sometimes especially, if you are pregnant....
The first quadrivalent human papillomavirus vaccine (HPV4) was licensed in the United States in 2006 (Gardasil, Merck & Co., Inc.). (1) It contains viral proteins from HPV types 18, 16, 11, and 6, the types currently responsible for 70% of cervical cancers and 90% of anogenital warts...
《Immunogenicity and safety of two novel human papillomavirus 4- and 9-valent vaccines in Chinese women aged 20–45 years: A randomized, blinded, controlled with Gardasil (type 6/11/16/18), phase III non-inferiority clin...